Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.28%5.59B | 7.69%23.32B | 3.13%5.26B | -2.81%21.65B | 1.31%5.4B | 1.07%5.27B | -7.62%5.88B | -4.95%5.1B | 3.14%22.28B | -2.49%5.33B |
| Cost of revenue | 3.59%4.5B | 6.82%19.05B | 3.59%4.34B | -3.80%17.83B | -0.25%4.4B | -1.18%4.3B | -7.10%4.95B | -5.94%4.19B | 5.23%18.54B | -2.41%4.41B |
| Gross profit | 18.98%1.09B | 11.74%4.27B | 1.05%918.89M | 2.12%3.82B | 8.75%1B | 12.45%966.73M | -10.28%939.62M | -0.08%909.36M | -6.12%3.74B | -2.86%921.39M |
| Operating expense | 1.82%674.41M | 3.30%2.89B | -6.93%662.37M | 6.61%2.8B | 2.23%651.49M | 16.94%779.43M | -2.26%653.45M | 9.40%711.73M | 1.69%2.62B | -2.92%637.25M |
| Operating profit | 63.28%418.84M | 34.87%1.38B | 29.79%256.51M | -8.43%1.02B | 23.35%350.48M | -3.05%187.29M | -24.44%286.18M | -23.84%197.63M | -20.47%1.12B | -2.73%284.14M |
| Net non-operating interest income (expenses) | 372.01%2.19M | 609.14%19.47M | 59.21%-804K | 181.03%2.75M | 1,051.90%3.95M | 1.63%-1.63M | 641.63%2.39M | -20.55%-1.97M | 29.70%-3.39M | 164.23%343K |
| Non-operating interest income | 259.29%6.54M | 176.83%34.74M | 220.99%1.82M | 177.14%12.55M | 176.15%6.19M | 204.37%1.11M | 206.09%4.67M | 44.64%567K | 38.43%4.53M | 70.31%2.24M |
| Non-operating interest expense | 65.85%4.35M | 55.74%15.27M | 3.39%2.62M | 23.82%9.8M | 18.05%2.24M | 35.68%2.74M | 15.79%2.28M | 25.21%2.54M | -2.16%7.92M | 2.65%1.9M |
| Net investment income | 8.88%97.03M | 6.70%214.43M | 2.50%89.12M | -10.61%200.96M | 10.41%-5.69M | -13.62%100.66M | -34.33%19.05M | 1.55%86.94M | 28.89%224.8M | -172.36%-6.35M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 206.26%255.23M | 255.23M | 83.34M | 0 | |||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -1,342.78%-7.59M | -228.09%-3.81M | -526K | 200.71%2.98M | 466K | 136.45%300K | 4.37%-2.96M | 0 | ||
| Less:Other special charges | 1,342.78%7.59M | 228.09%3.81M | --526K | -200.71%-2.98M | ---466K | -136.45%-300K | ---- | ---- | -4.37%2.96M | --0 |
| Other non-operating income (expenses) | -87.22%2.98M | -36.05%14.98M | 317.54%23.31M | 81.43%23.42M | 284.92%10.85M | -52.92%2.3M | 179.01%4.69M | -49.82%5.58M | 11.18%12.91M | -3.03%2.82M |
| Income before tax | -17.56%513.45M | 40.68%1.88B | 116.13%622.84M | -0.89%1.34B | 57.82%443.4M | -7.43%288.93M | -21.23%314.51M | -18.73%288.18M | -14.64%1.35B | -7.36%280.95M |
| Income tax | -14.69%126.63M | 27.96%532.25M | 70.11%148.44M | 23.20%415.94M | 83.15%146.46M | 58.73%109.37M | -26.88%72.85M | -2.06%87.26M | -18.80%337.6M | -7.84%79.96M |
| Net income | -18.46%386.82M | 46.43%1.35B | 136.11%474.4M | -8.94%919.08M | 47.75%296.94M | -26.17%179.56M | -19.35%241.66M | -24.33%200.92M | -13.16%1.01B | -7.17%200.98M |
| Net income continuous operations | -18.46%386.82M | 46.43%1.35B | 136.11%474.4M | -8.94%919.09M | 47.75%296.94M | -26.17%179.56M | -19.35%241.66M | -24.33%200.92M | -13.16%1.01B | -7.17%200.98M |
| Noncontrolling interests | 13.42%23.91M | 159.04%25.55M | 210.68%21.08M | -170.51%-43.27M | 41.30%21.12M | -619.14%-59.41M | -31.49%14.07M | -231.95%-19.05M | 2.18%61.36M | 7.66%14.94M |
| Net income attributable to the company | -19.95%362.9M | 37.19%1.32B | 106.08%453.32M | 1.51%962.35M | 48.26%275.83M | 3.10%238.96M | -18.45%227.59M | -12.39%219.97M | -13.99%947.99M | -8.19%186.04M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -19.95%362.9M | 37.19%1.32B | 106.08%453.32M | 1.51%962.35M | 48.26%275.83M | 3.10%238.96M | -18.45%227.59M | -12.39%219.97M | -13.99%947.99M | -8.19%186.04M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -19.03%82.67 | 37.22%297.41 | 106.10%102.1 | 1.51%216.74 | 48.26%62.12 | 3.10%53.82 | -18.45%51.26 | -12.40%49.54 | -13.99%213.51 | -8.17%41.9 |
| Diluted earnings per share | -19.03%82.67 | 37.22%297.41 | 106.10%102.1 | 1.51%216.74 | 48.26%62.12 | 3.10%53.8193 | -18.45%51.259 | -12.40%49.54 | -13.99%213.51 | -8.17%41.9 |
| Dividend per share | 0 | 0.00%40 | 0 | 0.00%40 | 0.00%20 | 0 | 0.00%20 | 0 | 0.00%40 | -4.76%20 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |